GFAP and COVID-19: Markers like NfL, Glial fibrillary acidic protein (GFAP and Total Tau protein were confirmed to be increased in 24 patients hospitalized after COVID-19; these markers indicate axonal injury, astrocyte injury and neuronal degeneration [21].